Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

A new study has found that the clot-dissolving drug alteplase can significantly improve stroke recovery even when given up to ...

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Doctors at UC Health are making strides in stroke care with the help of a new app created by a Walnut Hills High School alum.

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Alongside the World Bank and Ukraine’s Ministry of Health, a total of 25 Philips stroke treatment suites will be installed ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...

The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial ...

Royal Philips, in partnership with the World Bank and Ukraine's Ministry of Health, has launched an initiative aimed at ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...